These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11723066)

  • 1. Identification of novel genes differentially expressed in omental fat of obese subjects and obese type 2 diabetic patients.
    Corominola H; Conner LJ; Beavers LS; Gadski RA; Johnson D; Caro JF; Rafaeloff-Phail R
    Diabetes; 2001 Dec; 50(12):2822-30. PubMed ID: 11723066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes.
    Statnick MA; Beavers LS; Conner LJ; Corominola H; Johnson D; Hammond CD; Rafaeloff-Phail R; Seng T; Suter TM; Sluka JP; Ravussin E; Gadski RA; Caro JF
    Int J Exp Diabetes Res; 2000; 1(2):81-8. PubMed ID: 11469400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification of genes that are differentially expressed in omental fat of normal weight subjects, obese subjects and obese diabetic patients].
    Luo TH; Zhao Y; Li G; Zhang HL; Li WY; Ldu M
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2007 May; 23(2):229-34. PubMed ID: 21179778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression pattern of tumour necrosis factor receptors in subcutaneous and omental human adipose tissue: role of obesity and non-insulin-dependent diabetes mellitus.
    Hube F; Birgel M; Lee YM; Hauner H
    Eur J Clin Invest; 1999 Aug; 29(8):672-8. PubMed ID: 10457150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous adipose tissue expression of tumour necrosis factor-alpha is not associated with whole body insulin resistance in obese nondiabetic or in type-2 diabetic subjects.
    Koistinen HA; Bastard JP; Dusserre E; Ebeling P; Zegari N; Andreelli F; Jardel C; Donner M; Meyer L; Moulin P; Hainque B; Riou JP; Laville M; Koivisto VA; Vidal H
    Eur J Clin Invest; 2000 Apr; 30(4):302-10. PubMed ID: 10759878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPAR-gamma gene expression is elevated in skeletal muscle of obese and type II diabetic subjects.
    Park KS; Ciaraldi TP; Abrams-Carter L; Mudaliar S; Nikoulina SE; Henry RR
    Diabetes; 1997 Jul; 46(7):1230-4. PubMed ID: 9200661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic and Type 2 diabetic subjects.
    Koistinen HA; Dusserre E; Ebeling P; Vallier P; Koivisto VA; Vidal H
    Diabetes Metab Res Rev; 2000; 16(5):364-9. PubMed ID: 11025560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes.
    Ducluzeau PH; Perretti N; Laville M; Andreelli F; Vega N; Riou JP; Vidal H
    Diabetes; 2001 May; 50(5):1134-42. PubMed ID: 11334418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty acid transport protein-1 mRNA expression in skeletal muscle and in adipose tissue in humans.
    Binnert C; Koistinen HA; Martin G; Andreelli F; Ebeling P; Koivisto VA; Laville M; Auwerx J; Vidal H
    Am J Physiol Endocrinol Metab; 2000 Nov; 279(5):E1072-9. PubMed ID: 11052962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiles of nondiabetic and diabetic obese mice suggest a role of hepatic lipogenic capacity in diabetes susceptibility.
    Lan H; Rabaglia ME; Stoehr JP; Nadler ST; Schueler KL; Zou F; Yandell BS; Attie AD
    Diabetes; 2003 Mar; 52(3):688-700. PubMed ID: 12606510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients.
    Rieusset J; Bouzakri K; Chevillotte E; Ricard N; Jacquet D; Bastard JP; Laville M; Vidal H
    Diabetes; 2004 Sep; 53(9):2232-41. PubMed ID: 15331532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of omentin in adipose tissues in obese and type 2 diabetic patients].
    Cai RC; Wei L; DI JZ; Yu HY; Bao YQ; Jia WP
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):381-4. PubMed ID: 19567114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of variations of gene expression of visceral adipose and renal tissue in type 2 diabetic rats using cDNA representational difference analysis.
    Yang J; Li G; Zhang F; Liu Y; Zhang D; Zhou W; Xu G; Yang Y; Luo M
    Chin Med J (Engl); 2003 Apr; 116(4):529-33. PubMed ID: 12875716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective regulation of phosphatidylinositol-3-kinase gene expression in skeletal muscle and adipose tissue of non-insulin-dependent diabetes mellitus patients.
    Andreelli F; Laville M; Ducluzeau PH; Vega N; Vallier P; Khalfallah Y; Riou JP; Vidal H
    Diabetologia; 1999 Mar; 42(3):358-64. PubMed ID: 10096790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human mesenteric adipose tissue plays unique role versus subcutaneous and omental fat in obesity related diabetes.
    Yang YK; Chen M; Clements RH; Abrams GA; Aprahamian CJ; Harmon CM
    Cell Physiol Biochem; 2008; 22(5-6):531-8. PubMed ID: 19088435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose uptake and insulin action in human adipose tissue--influence of BMI, anatomical depot and body fat distribution.
    Stolic M; Russell A; Hutley L; Fielding G; Hay J; MacDonald G; Whitehead J; Prins J
    Int J Obes Relat Metab Disord; 2002 Jan; 26(1):17-23. PubMed ID: 11791142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in adiponectin protein expression: effect of fat depots and type 2 diabetic status.
    Fisher FM; McTernan PG; Valsamakis G; Chetty R; Harte AL; Anwar AJ; Starcynski J; Crocker J; Barnett AH; McTernan CL; Kumar S
    Horm Metab Res; 2002; 34(11-12):650-4. PubMed ID: 12660876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of FTO in human adipose tissue is influenced by fat depot, adiposity, and insulin sensitivity.
    Bravard A; Veilleux A; Disse E; Laville M; Vidal H; Tchernof A; Rieusset J
    Obesity (Silver Spring); 2013 Jun; 21(6):1165-73. PubMed ID: 23913730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity.
    Garvey WT; Maianu L; Huecksteadt TP; Birnbaum MJ; Molina JM; Ciaraldi TP
    J Clin Invest; 1991 Mar; 87(3):1072-81. PubMed ID: 1999488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6.
    Bach D; Naon D; Pich S; Soriano FX; Vega N; Rieusset J; Laville M; Guillet C; Boirie Y; Wallberg-Henriksson H; Manco M; Calvani M; Castagneto M; Palacín M; Mingrone G; Zierath JR; Vidal H; Zorzano A
    Diabetes; 2005 Sep; 54(9):2685-93. PubMed ID: 16123358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.